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Table 1. Comparison of clinical and laboratory ﬁndigs of patients with and
without fQRS
fQRS present
(n¼91)
fQRS absent
(n¼157) p value
Age 64,8212,65 62,2611,38 0,102
Sex M/F 69/22 120/37 0,914
Hypertension (%) 48 (52,7) 72 (45,9) 0,296
Diabetes Mellitus (%) 21 (23,1) 29 (18,5) 0,384
Hyperlipidemia (%) 27 (29,7) 32 (20,4) 0,098
Cigarette habit (%) 55 (60,4) 92 (58,6) 0,776
Family history (%) 29 (31,9) 40 (25,5) 0,279
Chest pain duration (min) 194,62174,01 165,19171,51 0,196
SBP (mmHg) 132,8126,56 128,1526,22 0,181
DBP (mmHg) 79,3217,01 76,7316,91 0,248
Door to needle time (min) 29,119,43 26,908,08 0,181
LVEF (%) 34,836,76 46,756,22 <0,001
HB (gr/dl) 13,231,93 13,472,04 0,355
WBC (x103/mL) 12.9583.07 10.7803.38 <0,001
PLT (x103/mL) 227,8963,43 217,7871,74 0,266
BUN (mg/dl) 19,2413,72 17,486,18 0,248
Creatinine (mg/dl) 1,000,48 0,940,35 0,202
LDL-chol (mg/dl) 121,7931,06 121,9631,11 0,968
HDL-chol (mg/dl) 36,789,54 38,109,74 0,311
Maximum CK-MB (ng/ml) 228,27121,23 114,7785,55 <0,001
Maximum Troponin (ng/ml) 62,7353,49 29,7116,17 <0,001
QRS duration (msn) 107,868,95 102,779,21 <0,001
MI localization
Anterior MI (%)
Other (%)
35 (38,5)
56 (61,5)
71 (45,2)
86 (54,8)
0,300
(SBP: systolic blood pressure, DBP: diastolic blood pressure, LVEF: left ventricular ejection frac-
tion, HB: hemoglobin, WBC: white blood cell count, MPV: mean platelet volume, PLT: platelet
count, BUN: blood urea nitrogen, LDL-chol: low density lipoprotein-cholesterol, HDL-chol: high
density lipoprotein-cholesterol, CK-MB: creatinine kinase-muscle band,MI:myocardial infarction)
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Feasibility of GRACE and TIMI Scores in Predicting the Extension of Coronary
Artery Disease in Patients with Non ST Elevation Myocardial Infarction
Hale Unal Aksu1, S¸evket Gorgulu2, Ender Oner1, Mehmet Erturk1, Omer Celik1,
Huseyin Aksu1
1Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research
Hospital, Cardiology Department, Istanbul, 2Kocaeli Acibadem Hospital, Acibadem
University, Cardiology Department, Kocaeli
Aım: To assess the correlation of TIMI and GRACE risk scores with the SYNTAX
score as the surrogate of severity and extent of coronary artery disease in patients with
non-ST segment elevation myocardial infarction (NSTEMI).
Materıals-Methods: Patients admitted to our emergency department with chest pain,
meeting the criteria of NSTEMI and undergoing coronary angiography during hos-
pitalisation were considered for this study. Patients with ST segment elevation at
admission, new left bundle branch block, percutaneous coronary intervention in the
previous 6 months or previous coronary artery bypass graft surgery were excluded.
TIMI and GRACE risk scores were calculated and coronary artery disease severity
and extension were assessed by an experienced invasive cardiologist using the
SYNTAX score algorithm.
Results: We assessed 145 patients (mean age 59.4111.04 years, 29% female). A
positive correlation of the SYNTAX score was observed with GRACE scores for in-
hospital death, in-hospital death or MI, death at 6 month and death or MI at 6 month
(r¼0,414, p<0.0001; r¼0,370, p<0.0001; r¼0,417, p<0.0001; r¼0,415, p<0.0001,
respectively). The SYNTAX score also had a signiﬁcant but weaker correlation with
the TIMI score(r¼0,271, p¼0.001). The GRACE score showed good discriminatory
capacity between the patients with and without a high-risk (>33) SYNTAX score,
with an area under the ROC curve of 0.804 (CI 0.660–0.948, p¼0.002); however, theC212 JACC VoTIMI score showed no predictive capacity and had an area under the ROC curve of
0.532 (CI 0.358–0.749, p¼0.749).
Conclusıon: There is a positive association between GRACE, TIMI scores and
SYNTAX score in patients with NSTEMI. GRACE scores but not TIMI score can
predict the patients with high risk SYNTAX score (>33).
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Exercise ECG Test Should be Evaluated with Troponin T after Exercise in
Women with an Intermediate Pretest Probability
Sinan _Is¸cen
Diyarbakır Military Hospital, Diyarbakır
Background: A variety of tests are available to establish the diagnosis of coronary
heart disease. Coronary angiography is the deﬁnitive diagnostic test for the presence of
obstructive coronary artery disease. However, it is seldom used as the initial test
because of its invasive nature.More practice exercise ECG testing is most useful in
patients with an intermediate pretest probability (variably deﬁned as between 25 and
75 percent or between 10 and 90 percent). But diagnosing coronary artery disease is
more difﬁcult with exercise ECG test in women with an intermediate pretest proba-
bility, because accurancy of exercise ECG is low. So we aimed to increase PPV
(positive predictive value) of exercise ECG test together with used troponin T at fourth
hour after exercise in women with an intermediate pretest probability.
Material-Methods: The study group for the evaluation of the diagnostic value of
positive exercise ECG test and troponin T at fourth hour comprised 50 female patients
with an intermediate pretest probability. The average age of the patients was
46.084.1. All the patients underwent ECG stress test, and all of them also coronary
angiography as the next stage of the CAD deﬁnitive diagnosis process. During the test
their clinical condition, ECG and arterial pressure were monitored. All the patients had
positive exercise ECG test results. Additionally, the maximum pulse rate (MPR),
number of the achieved metabolic equivalents (MET), stage and reason for termina-
tion, if any, were analysed. The degree of coronary stenosis was assessed visually and
greater than 50% stenosis of the luminal diameter were considered haemodynamically
signiﬁcant (at any coronary). Troponin T was evaluated in all patient at fourth hour
after exercise ECG test. Troponin>0.04 pg/ml was approved positive.
Results: The PPV of only exercise ECG test was 42% in women with an intermediate
pretest probability. The PPV of exercise ECG test with troponin T(+) for positive
coronary angiography (requirement revascularization at any coronary) was 90%,
with troponin T(-) for positive coronary angiography was 30%. If compared,
exercise ECG test with troponin T(+) was a better diagnostic predictor of
CHD(coronary heart disease) was required revascularization (p<0.001).
Conclusıons: Exercise ECG test with troponin T(+) is superior to exercise ECG test
with troponin T(-) in the prediction of necessary revascularisation procedures in
women with an intermediate pretest probability and positive stress test results.PP-330
Relation of Mean Platelet Volume with Subclinical Atherosclerosis in Patients
with Metabolic Syndrome
Ali Rıza Gülcan1, Mustafa Serkan Karakas¸2, Barıs¸ Akdemir3, Mustafa Uçar4,
Reﬁk Emre Altekin4, Hüseyin Yılmaz4
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Objectıve: Metabolic syndrome (MetS) is associated with increased cardiovascular
morbidity and mortality. There is evidence of platelet activation in MetS. Mean
platelet volume (MPV), a determinant of platelet activation, is a newly emerging risk
factor for atherothrombosis. Therefore, we have investigated the possible association
between subclinical atherosclerosis,e valuated by carotid intima-media thickness
(CIMT) measurement and MPV in MetS patients.
MATERIAL/METHODS:: 74 patients with MetS were enrolled to the study.
Patients were divided into 2 groups according to CIMT measurement: 35 patients with
CIMT 1,0 mm were at group 1 and 39 patients with CIMT <1,0 mm were at group
2. MPV were measured using an automated blood cell counter.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
Results: Patients between ages 30 and 60 years with MetS diagnosis were included in
this study. 31 patients (41.9%) were male and 43 patients (58.9%) were female.
Patients were divided into 2 groups according to CIMT measurement: 35 patients with
CIMT 1,0 mm were at group 1 and 39 patients with CIMT<1,0 mm were at group 2.
There were difference only age and fasting blood glucose parameter among groups. In
the multi-varians analysis, age and fasting blood glucose related in CIMT values were
not statistically signiﬁcant (p>0.05). Additionally, the common effect of age and
fasting blood glucose variables on the CIMT values were not statistically signiﬁcant
(p¼0.241). The MPV level was signiﬁcantly higher in patients with CIMT 1,0 mm
than in patients with CIMT <1,0 mm (8.20.7 vs. 7.80.6 ﬂ; p¼0.01) (Figure 1).
Conclusıons: The risk of atherosclerosis could be shown with following the MPV
values in MetS patients. Therefore, our results suggest that MPV is an important
marker for early detecting the risk of atherosclerosis in patients with MetS. In our
study, we showed that this risk could be determined with a simple blood count. Risk
of atherosclerosis can be assessed by examining the values of MPV, without any
additional blood tests or radiological examination.Table 1
Group 1
CIMT 1,0 mm
(mean sd)
Group 2
CIMT<1,0 mm
(mean sd) P
Number of patients (n) 35 39
Age (years) 51.96.5 46.68.1 0.003
Gender (F/M, n) 23/12 19/20 0.16
BMI (kg/m2) 31.34.0
30 (25-42)
32.25.0
31 (26-46)
0.62
Waist circumference (cm) 102.19.7 104.210.6 0.38
HT [n(%)] 14(40.0) 15(38.4) 0.94
DM [n(%)] 15(42.9) 10(25.6) 0.08
Smoking [n(%)] 6(17.1) 9(23.0) 0.33
SBP (mmhg) 128.111.8
130 (100-160)
124.612.5
120 (110-160)
0.09
DBP (mmhg) 81.87.1
80 (60-100)
79.47.1
80 (70-100)
0.06
Fasting glucose (mg/dl) 114.424.7
109 (76-206)
106.130.3
101 (81-260)
0.02
HbA1c (%) 6.30.9 6.10.99 0.37
HDL-cholesterol (mg/dl) 44.111.2 39.512.7 0.10
LDL-cholesterol (mg/dl) 116.536.1 120.739.2 0.63
Triglyceride (mg/dl) 178.180.8 217.6108.9 0.08
Hemoglobin (g/dl) 13.31.2 13.61.4 0.23
Platelet (x109/l) 256.461.2 286.866.2 0.04
MPV (ﬂ) 8.20.7 7.80.6 0.01
Baseline characteristcs of patients (BMI: body mass index, HT: hypertension, DM: diabetes
mellitus, SBP: systolic blood pressure, DBP: diastolic blood pressure, LDL: low-density lipo-
protein, HDL: high-density lipoprotein, MPV: mean platelet volume
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Endothelin Antagonists may be a Treatment Option for Cardiac Syndrome X, or
Not ?
S¸eyda Günay, _Ibrahim Baran, Ali Aydınlar, Osman Akın Serdar, Sümeyye Güllülü,
Dilek Yes¸ilbursa, Bülent Özdemir, Aysel Aydın Kaderli, Tunay S¸entürk, Saim Sag
Uludag University Faculty of Medicine Department of Cardiology, Bursa
Atherosclerosis is a systemic disease which effects large and medium sized arteries
besides coronary arteries. Atherosclerosis and associated diseases are the leading
cause of death all over the world. It is known that endothelial dysfunction already
starts before atherosclerotic involvement of coronary arteries. To diagnose athero-
sclerosis before organ damage has occured is important. The aim of the study is to
evaluate the relationship between endothelial dysfunction and serum endothelin-1
levels, small artery elasticity, coronary artery disease severity and also to seek an
answer if endothelin-1 antagonists may be beneﬁcal for cardiac Syndrome X or not.
Patients with chest pain were evaluated with exercise stress test or myocardial
perfusion scintigraphy. Then ischemia deteceted patients underwent elective coronary
angiography. Using ELISA method serum endothelin-1 levels of all patients were
measured and a radial artery tonometer was used to measure arterial elasticity of all
patients. The patients were grouped according to coronary artery disease history,
ischemia existence and coronary angiogram results. The groups were compared with
regards to serum endothelin-1 level, small artery elasticity and Gensini scores.
In the study group, 50 patients (62,5%) were male and 30 (37,5%) were female and
the average age was 58,4 10,7 years. Twenty six (32,5%) of the patients had
coronary artery disease history. Ischemia was present in 55 (68%) patients. Critical
coronary lesions were present in 21 (38%) patients who underwent coronary angi-
ography. Median serum endothelin-1 level was 18,9 ng/L (8,5-134,9 ng/L) in patients
with ischemia and 14,8 ng/L (8,4-41,5 ng/L) in patients without ischemia. Serum
endothelin-1 level of ischemic patients was higher (p¼0.045). There wasn't a statisti-
cally signiﬁcant relationship between serum endothelin- 1 levels and coronary artey
disease history, small artery elasticity, Gensini scores.
Because of serum endothelin-1 level of patients without coronary artery disease history
but with ischemia and normal coronary angiograms was higher than non-ischemic
patients, it is assumed that endothelin-1 antagonistsmaybebeneﬁcal for cardiacSyndrome
X. To support this, there is a need for large prospective population based studies.
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The Relationship between Serum 25-hydroxyvitamin D levels and In-Stent
Restenosis in Patients with Stable Coronary Artery Disease
Alparslan Kurtul1, Mustafa Duran1, Mikail Yarlıoglues¸1, Muhammed Karadeniz1,
Gökhan Ergün1, Ertan Vurus¸kan2, Emre Akkaya2, Sani Namık Murat1
1Ankara Education and Research Hospital, Ankara, 2Gaziantep Government
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Background: It has been shown that low levels of 25-hydroxyvitamin D are asso-
ciated with increased cardiovascular risk factors and events. The relationship between
serum 25-hydroxyvitamin D level and in-stent stenosis was investigated in our study.
Methods: A total of 181 patients with stable coronary artery disease and previously
implanted (>3 months) bare-metal stent were included in the study. Two groups were
formed according to angiographic results as Group 1 (50% in-stent stenosis) and
Group 2 (<50% in-stent stenosis). Serum 25-hydroxyvitamin D measurements were
performed by reverse-phase HPLC.
Results: The mean serum 25-hydroxyvitamin D level was found to be signiﬁcantly
lower in Group 1 compared to Group 2 (17.75.3 ng/ml and 20.96.7 ng/ml, p<0.01,
respectively) and length of stent was longer in Group 1 compared to Group 2
(18.75.3 mm and 17.111.2 mm, p<0.01, respectively). In multivariate logistic
regression analysis, only low level of serum 25-hydroxyvitamin D was an independent
risk factor for in-stent stenosis (p<0.01, OR¼0.915, 95% CI 0.866-0.967).
Conclusıon: Our results suggest that lower levels of 25-hydroxyvitamin D are
associated with an increased risk of in-stent stenosis.
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High Prevalence of Glucose Intolerance and Diabetes in Patients with Coronary
Artery Disease
Sinan Varol, Vedat Sansoy, Okay Abacı, Muhsin Kalyoncuoglu
Institute of Cardiology, Istanbul University, Istanbul
Purpose: Our purpose was to investigate the relationship between the prevalence of
glucose intolerance and type 2 diabetes with cardiometabolic risk factors in patients
with asymptomatic coronary artery disease.
Methods: 132 patients who had not been previously diagnosed with glucose intol-
erance or diabetes, and had coronary artery disease (CAD) were enrolled. 2 hour
standard oral glucose tolerance test (OGTT) with 75 gr. glucose was conducted.
Patients were divided into two groups as normal and with impaired glucose tolerance
(IGT) or diabetes (DM). Groups were compared according to waist circumference,
body-muscle index, creatinin clearance, risk factors of CAD, severity of CAD,
functional capacity, angina score. In patients with Fasting plasma glucose (FPG)<100
mg/dl, HOMA-IR values were investigated. For statistical analysis, t-test, Mann-
Whitney U, Kruskal Wallis or logistic regression test were used.
Result: Prevelance of IGT(%26) or DM (%4) was %30 in patients with CAD. %27 of
patients had a value of FPG <100 mg/dl before the test was conducted. Between theERS C213
